Volume | 8,451 |
|
|||||
News | - | ||||||
Day High | 7.8699 | Low High |
|||||
Day Low | 7.55 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Profound Medical Corporation | PROF | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.77 | 7.55 | 7.8699 | 7.70 | 7.76 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
101 | 8,451 | $ 7.71 | $ 65,192 | - | 7.11 - 15.49 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 100 | $ 7.70 | USD |
Profound Medical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
226.05M | 21.37M | - | 7.2M | -28.57M | -1.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Profound Medical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROF Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.74 | 8.0799 | 7.30 | 7.79 | 22,834 | -0.04 | -0.52% |
1 Month | 8.26 | 8.68 | 7.30 | 8.08 | 25,933 | -0.56 | -6.78% |
3 Months | 9.55 | 9.55 | 7.30 | 8.41 | 36,992 | -1.85 | -19.37% |
6 Months | 9.12 | 11.69 | 7.11 | 8.47 | 42,473 | -1.42 | -15.57% |
1 Year | 11.96 | 15.49 | 7.11 | 9.74 | 32,703 | -4.26 | -35.62% |
3 Years | 19.08 | 20.72 | 3.10 | 10.45 | 48,564 | -11.38 | -59.64% |
5 Years | 9.98 | 28.97 | 3.10 | 13.32 | 56,254 | -2.28 | -22.85% |
Profound Medical Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner. |